HOME >> BIOLOGY >> NEWS
Chemoradioimmunotherapy for advanced breast cancer: hope for the future?

A successful, and novel, technique to kill metastatic breast cancer cells by circumventing their chemo- and radioresistant mechanisms was by presented by Dr. John Giannios, Head of Radiotherapeutic Cancer Research at the IASO Hospital, Athens, Greece at the 18th Annual Meeting of the European Association of Cancer Research today (Tuesday 6 July 2004).

Advanced breast cancer, with metastases to lung and bone, has a very poor prognosis and current treatment protocols for this stage of disease generally result in survival periods of less than two years. One of the reasons for this poor prognosis is that metastatic cancer cells are less responsive to treatment than primary tumour cells. This is partly caused by the fact that the normal cell death process (apoptosis) is repressed by the overexpression of oncogenes such as bcl-2, HER-2, Raf-1 and cdc25c (these oncogenes are expressed more strongly in metastatic tumour cells), which means that the cells fail to die following treatment with chemotherapy drugs and radiation therapy.

Using metastatic tumour tissue taken from a patient with advanced breast cancer, Dr. Giannios's team analysed the cells to determine if known oncogenes were being overexpressed. In addition to finding overexpression of the oncogenes bcl-2, HER-2, Raf-1 and cdc25c they also detected overexpression of DNMT1 (a DNA methyltransferase, involved in DNA replication during cell division, and implicated in cancer development) and they also detected methylation of BRCA1 promoter (a process implicated specifically in the development of breast cancer tumours).

The experimental treatment, termed 'chemoradioimmunotherapy', combined chemotherapy, radiation therapy and immunotherapy in one. The chemotherapy component consisted of vinorelbine-tartrate (a cytotoxic drug used in the treatment of breast (and other) cancers), the radiotherapy component was provided through the addition of high energy radioisotopes, whilst the immunotherapy as
'"/>

Contact: Stuart Bell
stuart@fecs.be
00-32-0-495-27-2838
Federation of European Cancer Societies
6-Jul-2004


Page: 1 2 3

Related biology news :

1. Drug combo effective in advanced breast cancer
2. New drug target and biomarker for advanced childhood cancer discovered
3. Launch of Ariadna to boost advanced space research in Europe
4. Scientists develop advanced sensors for biological agent detection
5. Illinois lands research center for advanced water purification
6. New study expands look at high-dose vitamin D with docetaxel for advanced prostate cancer patients
7. Dynamic brain atlas may help diagnose patients using advanced brain scans
8. Old drug shows promise for helping treat advanced lung cancer
9. Marimastat produces comparable survival rates to chemotherapy in some advanced pancreatic cancer patients
10. SGX signs agreement to build state-of the-art beamlines at advanced photon source
11. UNC opens first clinical trial of vaccine treatment for advanced breast cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/10/2019)... ... 2019 , ... Cardea is excited to announce the finalization ... first broke the news of the proposed merger in September, along with ... CRISPR-Chip technology, the Genome Sensor is the world’s first DNA search engine. It ...
(Date:10/10/2019)... ... October 10, 2019 , ... Mindray, a global developer of ... American Society of Anesthesiologists 2019 Annual Meeting to visit exhibit #841 and discover ... Florida, and will provide more than 14,000 healthcare professionals from around the world ...
(Date:10/8/2019)... , ... October 08, 2019 , ... ... announced new apps that make it easier than ever for businesses and organizations ... The new Countdown App enables organizations to count down to or count up ...
Breaking Biology News(10 mins):
(Date:10/10/2019)... ... October 09, 2019 , ... ... of Montgomery County middle school and high school students have improved neuro-cognitive executive ... relaxation techniques and physical fitness, and apply lifelong social/interpersonal, leadership, problem-solving and coping ...
(Date:10/8/2019)... MELBOURNE, Fla. (PRWEB) , ... October 07, 2019 ... ... and development of low level laser therapy technology (“3LT®”), today announces that the ... to market its EVRL low level laser for the temporary relief of chronic ...
(Date:10/3/2019)... ... October 02, 2019 , ... ... sciences leadership firm that is enabling clinical program outsourcing success by cultivating radical ... award-winning pharma and biotech veteran executive Brenda Reese, phaseUP™ brings clients deep, broad ...
(Date:10/3/2019)... ... October 03, 2019 , ... Yesterday, at the 2019 meeting of Outsourcing ... director, James L. Sherley, M.D., Ph.D., discussed important design factors that currently limit the ... both developers and suppliers of clinical trials, in his talk Dr. Sherley ...
Breaking Biology Technology:
Cached News: